OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 15 filers reported holding OCUPHIRE PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $432 | -39.3% | 99,600 | -47.6% | 0.00% | 0.0% |
| Q1 2023 | $712 | +6.4% | 189,969 | +0.2% | 0.00% | 0.0% |
| Q4 2022 | $669 | -99.8% | 189,500 | -8.4% | 0.00% | 0.0% |
| Q3 2022 | $416,000 | +9.2% | 206,901 | +4.4% | 0.00% | – |
| Q2 2022 | $381,000 | +429.2% | 198,190 | +923.7% | 0.00% | – |
| Q4 2021 | $72,000 | -61.7% | 19,361 | -45.5% | 0.00% | – |
| Q2 2021 | $188,000 | -71.5% | 35,529 | -68.7% | 0.00% | -100.0% |
| Q1 2021 | $660,000 | +37.8% | 113,620 | +53.9% | 0.00% | 0.0% |
| Q4 2020 | $479,000 | – | 73,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
| Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
| MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
| Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
| Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |